Datu Oto, Abuhair A.

HRN: 28-80-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
CEFUROXIME 750MG (VIAL)
07/01/2026
07/07/2026
IV
245mg
Q8hours
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines